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Abstract Myotonic dystrophy protein kinase (DMPK) is the
protein product of the human DM-1 locus on chromosome
19q13.1 and has been implicated in the cardiac and behavioral
dysfunctions of the disorder. DMPK contains four distinct re-
gions: a leucine-rich repeat (L), a serine-threonine protein ki-
nase catalytic domain (PK), an K-helical coiled-coil region (H),
and a putative transmembrane-spanning tail (T). Multiple pro-
tein kinases that participate in cytoskeletal and cell cycle func-
tions share homology with DMPK in the PK and H regions.
Here we show that the LPKH and PKH subfragments of
DMPK formed dimers of 140 000 molecular weight, whereas
the LPK subfragment remained a monomer of 62 000 apparent
molecular weight. The H domain thus appeared to be required
for dimerization of DMPK subfragments. Caspase 1 cleaved
LPKH between the PK and H regions. After cleavage, LPKH
dimers became LPK-like monomers, consistent with the H do-
main mediating dimerization. The Vmax and kcat/Km of LPKH
with a synthetic peptide kinase substrate were over 10-fold
greater than either LPK or caspase-cleaved LPKH. The Km
of dimeric LPKH was over three-fold greater than those of
the monomeric proteins. Dimerization appeared to signi¢cantly
a¡ect the catalytic e⁄ciency and substrate binding of DMPK.
These interactions are likely to be functionally signi¢cant in
other members of the myotonic dystrophy family of protein ki-
nases with extensive coiled-coil domains.
4 2003 Federation of European Biochemical Societies. Pub-
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1. Introduction
Myotonic dystrophy protein kinase (DMPK) is the protein
product encoded by the DM-1 locus on human chromosome
19q13.3 in which expansion mutations of a GCT repeat pro-
duce myotonic dystrophy type 1 (DM-1) [1]. Several isoforms
may be produced by alternative splicing, primarily a¡ecting
the expression of the carboxy-terminal region and putative
transmembrane-spanning (T) domain [2]. Although the myo-
tonia and insulin resistance of DM-1 may be explained by
gain-of-function e¡ects at the mRNA level unrelated to
DMPK expression [3^6], haploinsu⁄ciency of DMPK expres-
sion has been demonstrated in material from a¡ected patients
[7^9]. Furthermore, knockout mice null for DMPK expression
show the cardiac arrhythmias that are life-threatening in hu-
man DM-1 patients and altered synaptic plasticity in the hip-
pocampus that is potentially related to the cognitive de¢cits
and mental retardation seen in DM-1 [10^13]. The cardiac
arrhythmias appear in mice heterozygous for the DMPK
knockout suggesting that even a partial reduction of DMPK
may be functionally signi¢cant.
DMPK is the canonical member of the myotonic dystrophy
family of protein kinases (MDFPK) [14]. Several functional
and structural characteristics of DMPK are related to the
properties of the other protein kinases of this family including
Neurospora Cot-1 [15], Drosophila Warts [16], rat ROKK [17],
human p160ROCK [18], human PK428 [14], Caenorhabditis ele-
gans LET-502 [19], Drosophila Genghis Khan [20], murine
Citron Rho-interacting kinase [21], rat DM kinase-related
Cdc42 binding kinase [22] and C. elegans DM kinase-related
kinase (M. Shimizu and H.F. Epstein, unpublished results).
All family members are serine-threonine kinases which show
strong conservation in their catalytic protein kinase (PK) do-
mains (Fig. 1). They also have varying lengths of K-helical,
coiled-coil-forming sequences. Most have been shown to be
regulated by a member of the Ras superfamily of p21
GTPases and to be involved in cytoskeletal and cell cycle-
related processes. Previous work from our and other labora-
tories veri¢ed by enzymological studies of recombinant pro-
teins that DMPK is a functional serine-threonine protein ki-
nase [23^25]. We have also shown that DMPK is activated by
Rac-1 by cotransfection in Cos-M6 cells [26]. The interaction
with Rac-1 and structural similarities to Rho-kinase stimu-
lated studies of the e¡ects of DMPK on enhancing the orga-
nization of the actin cytoskeleton [27], which culminated in
the ¢nding that DMPK phosphorylates the myosin binding
subunit of myosin phosphatase (MYPT1) and inhibits the
activity of myosin light chain phosphatase [28]. These studies
suggest that DMPK may function in a role complementary to
Rho kinase in the regulation of the cytoskeleton.
An interesting structural feature of MDFPK enzymes is the
presence of long stretches of K-helix of varying length. DMPK
contains residues 461^538 within the K-helical (H) region that
are predicted to form a coiled coil [29]. Homologous sequen-
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ces to this region have been shown to be necessary for the
binding of Rho, a Ras superfamily GTPase [17]. We report
here that the K-helical coiled-coil region is necessary for the
formation of DMPK homodimers and that the dimeric form
enhances the catalytic e⁄ciency of the kinase active centers.
These structural and functional ¢ndings in DMPK are likely
to be signi¢cant in understanding the structure^function rela-
tionships of other important MDFPK members such as Rho
kinase.
2. Materials and methods
2.1. cDNA constructs
Full-length and truncated subfragments of human DMPK
(AAC14449) were cloned in-frame into the EcoRI and BamHI sites
of insect cell expression vector pVL1392 (PharMingen). For puri¢ca-
tion and detection of DMPK, a poly-His tag and a FLAG/hemagglu-
tinin antigen (HA) epitope tag were added at the N- and C-termini of
DMPK respectively. pVL1392 His-LPKHT-FLAG, pVL1392 His-
LPKH-FLAG, pVL1392 His-LPK-FLAG, pVL1392 His-PKH-
FLAG, pVL1392 His-LPKH-HA and pVL1392 His-PKH-HA were
constructed for protein expression. All constructs were sequenced to
con¢rm their correct sequences and reading frames.
2.2. Protein expression and puri¢cation
The cDNA constructs of DMPK were transfected into Sf9 cells.
Brie£y, 0.5 Wg baculovirus DNA and 2 Wg plasmid mixture were
cotransfected into 2U106 Sf9 cells. The transfected cells were incuba-
ted for 5 days at 27‡C. The supernatant which contained recombinant
virus for protein expression was collected. 1 ml of ampli¢ed virus was
added to 2U107 Sf9 cells and incubated for 3 days at 27‡C. The cells
were harvested and spun at 5000Ug for 5 min. The pellets were
suspended in lysis bu¡er (20 mM Tris^HCl pH 7.5, 150 mM NaCl,
1 mM EDTA, 1 mM dithiothreitol (DTT), 1% Triton X-100, 2 mM
phenylmethylsulfonyl £uoride, 3 WM benzoyl-L-arginine ethyl ether,
3 WM N-p-tosyl-L-arginine methyl ester, 2 WM each of chymostatin,
leupeptin and pepstatin, 2 mM sodium orthovanadate and sodium
£uoride). The cells were passed through a 27 gauge needle six times,
then centrifuged at 14 000Ug for 10 min. 6 ml lysates were injected
into 5 ml Hi-Trap Column. The binding column was washed with lysis
bu¡er with increasing concentrations of imidazole (10, 30 mM) until
the UV absorbance of the wash was constant, and then eluted with
200 mM imidazole. The eluted proteins were desalted and injected
into a 5 ml DEAE column equilibrated with bu¡er (20 mM Tris^
HCl pH 7.0). The bound protein was washed with bu¡er with increas-
ing concentrations of NaCl (50 and 150 mM) until the constant UV
absorbance of the eluant was reached. The proteins were eluted with
300 mM NaCl in bu¡er 1. The eluted protein were concentrated and
stored in liquid nitrogen.
2.3. Sucrose density gradient sedimentation (SDGS)
A linear 5^20% (w/v) sucrose gradient solution was constructed
with lysis bu¡er with a ¢nal volume of 9.0 ml. 1.0 ml of 2U107
infected cell lysate or 1.0 ml of 0.8 mg/ml puri¢ed protein was layered
on the top of the sucrose gradient. The protein sample and sucrose
gradient combinations were spun in an SW41.1 swinging-bucket rotor
(Beckman) at 29 000 rpm (about 100 000Ug) for 16^20 h for LPKH,
16 h for LPK and 20 h for PKH. 1 ml fractions were collected and
each fraction was further analyzed by sodium dodecyl sulfate^polyac-
rylamide gel electrophoresis (SDS^PAGE). Apparent molecular
weights were determined by relative sedimentation with respect to
proteins of known molecular weights [30].
2.4. Sedimentation equilibrium analysis
The molecular weights of the DMPK construct were measured in
20 mM Tris^HCl pH 7.5, 150 mM NaCl with a Beckman Coulter XL
analytical ultracentrifuge and an An60Ti rotor. Sedimentation equi-
librium was performed at 4‡C with six channel Epon centerpieces and
scanned at 14, 16, 18, and 25 h at 7000 rpm, then scanned at 14, 16,
18, and 25 h at 9000 rpm, and then scanned at 14, 16, 18, and 25 at
11 000 rpm sequentially. The data were analyzed with software (Origin
Microcal Software, 1995) provided by Beckman Coulter. The partial
speci¢c volume of LPKH was assumed to be 0.725 cm3/g. All samples
were visually checked for clarity after ultracentrifugation, and no in-
dication of precipitation was observed.
2.5. Protein kinase assays
Puri¢ed DMPK subfragments were analyzed using histone H1 and
the MYPT1 regulatory peptide (residues 690-RQSRRSTQGVTLTD-
703) as substrate [28]. DMPK (LPKH, LPK, PKH) subfragments
were incubated with 100 WM ATP, 3 WCi of [32P]Q-ATP and 12 WM
of MYPT1 peptide or 3 Wg of histone H1 in 40 Wl of kinase bu¡er
(20 mM Tris^HCl pH 7.5, 0.25 mM MgCl2, 30 mM KCl, 0.5 mM
DTT, 0.5 mM EGTA, 1 WM microcystin-LR, 0.5 mg/ml bovine serum
albumin (BSA)) for 20 min at 30‡C. The reactions were terminated by
adding 6 Wl of acetic acid to each. 11.5 Wl of each reaction was spotted
onto Whatman P81 cellulose phosphate ¢lter circles. P81 ¢lter circles
were washed three times with 400 ml of cold 0.4% phosphoric acid for
10 min. 32PO4 incorporation was measured by counting the pads in a
Beckman scintillation counter. Each reaction was repeated three
times, and the resulting data were summarized as meanTS.D. Auto-
phosphorylation assay samples were subjected directly to SDS^PAGE
and autoradiographed.
2.6. In vitro protein binding assays
Puri¢ed recombinant DMPK subfragments from insect cells were
used for the protein binding assays. 1 WM of DMPK-FLAG and 3 WM
of DMPK-HA were used in all reactions. DMPK with FLAG-tagged
proteins were immobilized by anti-FLAG M2 a⁄nity gel (Sigma) in
binding bu¡er (20 mM Tris^HCl pH 7.5, 30 mM MgCl2, 100 mM
NaCl, 1 mM DTT, 0.5% Triton X-100, 0.5 mg/ml BSA). Then DMPK
with HA-tagged proteins was added and incubated for 3 h at 4‡C with
rocking. The beads with bound proteins were washed three times with
binding bu¡er and eluted by boiling. The eluted protein was identi¢ed
by anti-HA-Tag polyclonal antibody (Clontech), followed by second-
ary goat anti-rabbit antibody conjugated to alkaline phosphatase. The
signal was detected using a chemiluminescent detection system.
2.7. Caspase 1 cleavage
Puri¢ed LPKH from insect cells was assayed as substrate for cas-
pase 1. 1.6 Wg of LPKH and 60 U of caspase 1 (Biomol0) were
Fig. 1. The myotonic dystrophy family of protein kinases. The cata-
lytic domains of these related protein kinases were compared in
terms of identity of aligned amino acid sequences to DMPK. The
phylogenetic tree was constructed by pairwise comparisons of se-
quences [29].
Fig. 2. Protein modules of DMPK and its subfragments used in this study. The LPKH, LPK, and PKH constructs of DMPK were used.
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incubated in bu¡er (50 mM HEPES pH 7.4, 100 mM NaCl, 1 mM
EDTA, 10 mM DTT, 10% glycerol, 0.1% CHAPS) for 3 h at 30‡C
[34]. The mixture was then subjected to SDS^PAGE with a 5^20%
acrylamide gradient.
3. Results
3.1. DMPK constructs and subfragments
Fig. 2 shows the distinct regions of full-length DMPK
(LPKHT) and the three subfragments and DMPK used in
the experiments of this report. LPKH and PKH were selected
because they contain the catalytic PK domain and the K-he-
lical H region whereas LPK like LPKH contains the NH2-
terminal leucine-rich region (L) and catalytic PK structures
but lacks the H region. The study of these three subfragments
permitted us to analyze the role of the H region in homodi-
merization and enzymatic activity. LPKHT and the truncated
subfragments LPKH, LPK, and PKH were expressed as re-
combinant proteins in Sf9 cells. All the proteins were poly-
His-tagged at their NH2-termini and FLAG-tagged at their
COOH-termini. Their expression as proteins was tested by
Western blots with anti-FLAG monoclonal antibody. We pu-
ri¢ed LPKH, LPK, and PKH by nickel a⁄nity and DEAE
anion exchange chromatography on the Amersham/Pharma-
cia FPLC system.
3.2. LPKH is a homodimer
DMPK is a homooligomer [23,25,31], but whether native
DMPK is a homodimer or higher order multimer has not
been determined. To examine the native structure of
DMPK, LPKHT was expressed at low levels in Sf9 cells
and appeared to be insoluble (data not shown). Because the
T region appears to be a putative transmembrane domain,
LPKHT is probably localized to membranes [24,31]. In sepa-
rate experiments, LPKHT also appeared to be insoluble when
expressed in Escherichia coli. In contrast, LPKH was ex-
pressed abundantly as a soluble protein in Sf9 cells. Because
Fig. 3. SDGS shows that LPKH is a dimer. LPKH-containing insect cell lysates were analyzed on 5^20% SDGS. A: Lanes 1^9 were fractions
collected from top to bottom. The top panel was an SDGS of marker proteins: albumin, 67 000 (major band shown in lanes 2^4), catalase,
232 000 (major band shown in lanes 5^7), and aldolase, 158 000 (major band shown in lanes 4 and 5). The middle panel shows a parallel
SDGS of LPKH in an insect cell lysate. Its major band appeared in lanes 3^5. The major band of LPKH was also detected by Western blot
as shown in the lower panel; samples (5 Wl) of each fraction were analyzed by Western blot. The apparent molecular weight of LPKH was cal-
culated to be 140 000. Since the molecular weight of the LPKH monomer is 63 200 based upon the predicted amino acid sequence, native
LPKH appeared to be a dimer. B: Quanti¢cation of marker proteins and LPKH in Coomassie blue-stained SDS^PAGE of the SDGS analyses.
Albumin (F), aldolase (R), catalase (b), LPKH (O).
Fig. 4. Determination of the molecular weight of puri¢ed LPKH by
sedimentation equilibrium. Puri¢ed LPKH at three di¡erent concen-
trations, 1.2 Wg/Wl, 0.6 Wg/Wl, and 0.3 Wg/Wl, was spun for 25 h in
the Beckman Coulter XL ultracentrifuge at three di¡erent speeds
(7000 rpm, 9000 rpm and 11 000 rpm). The molecular weight of
LPKH was calculated as 140 258 from these experiments. The par-
tial speci¢c volume (v-bar) of LPKH was calculated to be 0.725
cm3/g based upon the predicted amino acid sequence (Origin Micro-
cal Software, 1995). Therefore, LPKH appeared to be a dimer as a
puri¢ed protein and in insect cell lysates.
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LPKH closely resembles an expressed spliceoform of DMPK
[2], we considered LPKH to be an appropriate model for
native DMPK in cells.
Lysates of infected cells expressing LPKH were subjected to
SDGS, and the protein was identi¢ed on Western blots by
anti-FLAG. The apparent molecular weight of LPKH in the
lysates was 140 000 by SDGS (Fig. 3) based upon the method
of Martin and Ames [30].
To further con¢rm these results, puri¢ed LPKH was
studied by sedimentation equilibrium experiments in the ana-
lytical ultracentrifuge. This analysis showed that LPKH be-
haves as a homogeneous species of 140 259 molecular weight
(Fig. 4) which is consistent with the SDGS results with lysates
and puri¢ed protein. Because the polypeptide molecular
weight as calculated from the predicted amino acid sequence
is 63 200, these results are most consistent with LPKH being a
homodimer.
3.3. The H domain is required for DMPK homodimerization
We next examined the LPK and PKH subfragments in
order to determine whether the H domain was required for
DMPK homodimerization. In SDGS, puri¢ed LPK behaved
as a species with the apparent molecular weight of 62 000 (Fig.
5). This result is consistent with LPK being a monomer be-
cause its molecular weight is 51 800 as calculated from the
predicted amino acid sequence for the LPK subfragment. In
contrast, PKH behaved as a dimer, suggesting that the H but
not L region is necessary for homodimerization (data not
shown).
To further con¢rm that the H domain is required for the
interactions between monomers leading to dimer formation,
we expressed LPKH and PKH as HA-tagged proteins in Sf9
cells in addition to the FLAG-tagged proteins. FLAG-tagged
DMPK subfragments were immobilized on an anti-FLAG M2
a⁄nity gel. HA-tagged DMPK subfragments were tested for
binding to the immobilized subfragments. These in vitro pull-
down assays were performed at 4‡C, and the DMPK subfrag-
ments pulled down were identi¢ed with anti-HA antibody. As
shown in Fig. 6, LPKH pulled down other LPKH and PKH
molecules. PKH also pulled down other PKH and LPKH
molecules, but LPK did not pull down either LPKH or
PKH. Because the H domain was present in both LPKH
and PKH but not in LPK, the two DMPK protein subfrag-
ments required the H but not the L region for their interac-
tion. The PK domain is clearly not su⁄cient for homodime-
rization. The predicted ability of the K-helical H domain
sequence from residues 461^538 to form a coiled coil is sug-
gested to be the structural basis for DMPK homodimeriza-
tion.
3.4. DMPK dimers have greater enzymatic activity than
monomers
DMPK phosphorylates the MYPT1 subunit and thereby
inhibits myosin phosphatase activity [28]. LPKH and LPK
activities were assayed with the 690-RQSRRSTQGVTLTD-
703 peptide of MYPT1 as substrate. This sequence contains
the phosphorylatable threonine which regulates myosin phos-
phatase activity [28]. The activity of LPK was less than half
that of LPKH under similar conditions (Fig. 7), and the Vmax
and kcat/Km of LPK were both signi¢cantly lower than those
of LPKH (Fig. 9A,C). LPKH also showed higher autophos-
phorylation activity than LPK. The Km of LPK for the pep-
tide substrate was signi¢cantly lower than that of LPKH as
well. Therefore, both the catalytic e⁄ciency and the binding
Fig. 5. SDGS of LPK. Puri¢ed LPK was analyzed. A: Lanes 1^9 were fractions collected from top to bottom. The upper panel was an SDGS
of marker proteins: albumin, 67 000 (major band show in lanes 3^5), ovalbumin, 43 000 (major band shown in lanes 3^4), and aldolase,
158 000 (major band shown in lanes 5^7). The lower panel was a parallel SDGS of LPK (major band shown in lanes 3^5). The apparent mo-
lecular weight of 62 000 for LPK was estimated from the results of three experiments. Considering the molecular weight of 51 800 calculated
from the predicted amino acid sequence and this result, LPK appeared to be monomeric. B: Quanti¢cation of marker proteins and LPK in
SDGS. Ovalbumin (b), albumin (F), aldolase (R) and LPK (O).
Fig. 6. The H domain is required for DMPK subfragment interac-
tions. FLAG-tagged DMPK protein subfragments (1 WM) were ad-
sorbed by anti-FLAG monoclonal antibody M2 beads to pull down
HA-tagged DMPK protein subfragments (3 WM), then the pulled
down subfragments were probed with anti-HA polyclonal antibody
in a Western blot of the SDS^PAGE. Mixture 1, LPKH-FLAG:
LPKH-HA; 2, LPK-FLAG:LPKH-HA; 3, PKH-FLAG:LPKH-
HA; 4, anti-FLAG M2 beads:LPKH-HA; 5, LPKH-FLAG:PKH-
HA; 6, LPK-FLAG:PKH-HA; 7, PKH-FLAG:PKH-HA; 8, anti-
FLAG M2 beads:PKH-HA. Lanes 4 and 8 represent control experi-
ments for the absence of binding of either LPKH-HA and PKH-
HA by anti-FLAG beads.
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of substrate by the active center of DMPK were a¡ected by
interactions within the homodimer in contradistinction to the
monomer.
3.5. Caspase 1 cleavage of LPKH removes the H domain,
produces monomers, and reduces kinase activity
In order to test whether the observed di¡erences in activity
between LPKH and LPK are the result of their dimeric versus
monomeric states or are the result of di¡erences in folding
during their expression or of perturbations during their puri-
¢cation, we studied the cleavage of LPKH by caspase 1. This
reaction produced two subfragments, the larger of which is
LPK-like in terms of polypeptide mobility on SDS^PAGE
(Fig. 8A). The NH2-terminal sequences of these two protein
subfragments (Fig. 8B) show that the sequence which precedes
the cleavage site, 369-LVED-372, is probably the substrate
binding site for caspase 1. This sequence shows strong simi-
larity to known sites for the protease [35]. SDGS showed that
the larger LPK-like subfragment behaved as a monomer (Fig.
8C). The kinase activity of LPKH was compared before and
after incubation with caspase 1. After cleavage, LPKH lost
about 60% of its kinase activity under the same assay condi-
tions. Lineweaver^Burk analysis revealed that the caspase
1-cleaved monomer like LPK had reduced Vmax, Km and
kcat/Km compared to uncleaved LPKH (Fig. 9B,C). These ex-
periments con¢rm the structural and functional signi¢cance of
the K-helical, coiled-coil H region.
Fig. 8. Caspase 1 cleaves DMPK to form a LPK-like protein and
reduces its activity. A: Caspase 1 cleaves LPKH. 1, LPKH; 2,
LPKH after caspase 1 incubation. LPKH was cleaved into two
bands. B: Caspase 1 cleavage site on DMPK. The NH2-terminal se-
quences of band 1 matched the NH2-terminal six-His tag
(GHHHHHHV) and four residues near the N-terminus of DMPK
(2-SAEV-5). The NH2-terminal sequence of band 2 (373-
GLTAMVSGGGET-384) matched sequence between the PK and H
domains. Caspase 1 cleaved to the NH2-terminal side of the indi-
cated amino acid residues of band 2. The preceding sequence 369-
LVED-372 is probably the caspase 1 substrate binding site [34].
C: SDGS showed that the LPK-like protein was a monomer. Cas-
pase 1-cleaved LPK-like protein was analyzed. Lanes 1^8 were frac-
tions collected from top to bottom. The upper panel contains an
SDGS of the marker protein: albumin, 67 000 (major band in lane
4); the middle panel contains an SDGS of the marker proteins oval-
bumin, 43 000 (major band in lane 3), and aldolase, 158 000 (major
band in lanes 5^6). The lower panel was an SDGS of LPK-like pro-
tein (major band shown in lane 4). The apparent molecular weight
of LPK-like protein was very close to albumin, 67 000. The LPK-
like protein appeared to be monomeric.
Fig. 9. Kinase activities of DMPK subfragments. A: Lineweaver^
Burk analysis showed signi¢cant di¡erences in the enzyme kinetics
of LPKH and LPK. 0.12 WM of each DMPK subfragment were in-
cubated with 1, 2, 3, 4, 5, 6 WM MYPT1 peptide for 20 min at
30‡C. R LPK, F LPKH. B: Lineweaver^Burk analysis shows that
caspase 1 digestion altered the enzyme kinetics of LPKH. 8 LPKH,
F LPK-like product of caspase 1 digestion of LPKH. The condi-
tions were similar to those in A. C: Vmax, Km and kcat/Km of
LPKH, LPK and LPK-like protein were calculated from the Line-
weaver^Burk analyses in A and B.
Fig. 7. LPKH has higher activity than LPK. A: Autophosphoryla-
tion. 0.5 WM DMPK in a total volume of 30 Wl was incubated for
30 min at 30‡C, and the mixtures were analyzed by SDS^PAGE.
The dried gel was radioautographed. The numbers below re£ect rel-
ative intensities of the bands: 1, LPKH (4.3); 2, LPK (2.8).
B: MYPT1 peptide phosphorylation. 0.12 WM DMPK and 12.5 WM
MYPT1 peptide in a total volume of 40 Wl were incubated for
20 min at 30‡C. 1, LPKH plus MYPT1 peptide; 2, LPK plus
MYPT1 peptide; 3, MYPT1 peptide alone.
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4. Discussion
The MDFPK enzymes show strong conservation both in
their catalytic domains and in long stretches of K-helix that
are compatible with the formation of coiled coils between
monomers. DMPK is the canonical member of the MDFPK
and may be considered a model for the general and functional
characteristics of this protein kinase family. The K-helical H
region between residues 461^538 is predicted by PAIRCOIL
to contribute to coiled-coil formation [29] (Fig. 10) with res-
idues 506^534 showing four clear heptad repeats. Our exper-
imental results suggest that this region is critical in the homo-
dimerization of DMPK polypeptides. Furthermore, the
homodimeric forms showed higher catalytic e⁄cacy than
monomeric forms that lacked the H region. Further research
is required to better understand the mechanism of how ho-
modimerization a¡ects the catalytic domain. Because our pre-
vious studies suggested that most of the apparent autophos-
phorylation activity in DMPK showed a marked dependence
on enzyme concentration [23], transphosphorylation between
the individual monomers in the homodimer may have an ac-
tivating e¡ect. Clearly in such a model, the catalytic PK do-
mains would interact directly with each other as the basis for
this activation.
Kinetic analysis of the dimeric LPKH and monomeric LPK
subfragments of DMPK revealed that LPKH showed a three-
fold greater kcat/Km and a 10-fold greater Vmax than LPK.
These di¡erences were also demonstrated when LPKH was
cleaved by caspase 1 to produce an LPK-like monomeric spe-
cies. These di¡erences are very likely to have physiological
and clinical signi¢cance. The kinetic di¡erences between di-
meric LPKH and monomeric LPK reported here re£ect their
relative e¡ects on actin cytoskeletal organization and mem-
brane blebbing [27]. DM patients show haploinsu⁄ciency in
the levels of DMPK mRNA and protein [7,8], consistent with
their heterozygous state for the autosomal dominant trait.
Moreover, mice that are heterozygous for the DMPK null
state show the age-dependent development of cardiac arrhyth-
mias that human DM patients exhibit [12]. These observations
suggest that reduced but present levels of the order of a two-
fold reduction in DMPK produce signi¢cant pathophysiolog-
ical changes in vivo. These di¡erences in DMPK concentra-
tions would be re£ected by comparable, two-fold di¡erences
in protein kinase activity. Thus, the enzyme kinetic di¡erences
that we have observed between the dimeric and monomeric
forms of DMPK are likely to be signi¢cant. All of the forms
of DMPK observed in vivo possess the H region and would
therefore be dimeric and show the higher activity [2].
Several studies from our laboratory indicate that DMPK
acts in the regulation of the cytoskeleton. Transfection of
DMPK into human and rabbit eye lens epithelial cells produ-
ces a striking rearrangement of the cortical actin cytoskeleton
[27]. Similar observations have been made in rat PC12 cells
that are a well-known model of neural cells (H.F. Epstein, S.
Li, Q. He and F. Liu, unpublished results). These rearrange-
ments are similar to the e¡ects of transfecting the Ras family
p21 GTPases RhoA and Rac-1. DMPK, indeed, can bind
Rac-1 and be activated three-fold by cotransfection with this
established regulator of the actin cytoskeleton [26]. Interest-
ingly, the H region contains the binding site for RhoA in
several kinases [17,20,22,33]. DMPK shows a very similar
pattern of phosphorylation and inhibition of the regulatory
MYPT1 subunit of myosin light chain phosphatase to the
e¡ects of RhoA-activated protein kinase [28]. Myosin phos-
phatase directly regulates the assembly and contractile proper-
ties of cytoskeletal myosin II which, in turn, are critical to the
assembly and function of the cortical actin cytoskeleton. As
with DMPK, loss-of-function mutants of myosin II in C. ele-
gans show semi-dominance [32]. That is, about two-fold re-
ductions in active myosin produce signi¢cant e¡ects in muscle
in vivo.
We propose that homodimerization of DMPK and other
MDFPK enzymes is important in producing physiologically
necessary levels of protein kinase activity. The H region in
DMPK and homologous regions in other MDFPK kinases
would be necessary for this homodimerization. This region
has also been shown to be important for interaction with
the p21 GTPases that regulate these kinases. DMPK like oth-
er MDFPK enzymes is likely to participate in the regulation
of cytoskeletal actin and myosin function.
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